His research focuses on artificial intelligence and multi-organ transplantation analytics. It covers allograft transplantation, rejection, antibodies and populational sciences. Pr. Loupy defended two PhD in cell biology (2011) and biostatistics (2014). Since 2015, Pr. Loupy is heading the Paris Expertise Centre for Organ Transplantation in PARCC U970. The Paris Transplant Group is recognised in the transplant research field and has changed clinical practice with wide implementation of discoveries into clinical practice. Since 2017, he is also Appointed Professor of Nephrology and Epidemiology Kidney Transplant department at the Necker Hospital in Paris, France. Pr. Loupy has been appointed as Director of the Banff Scientific Committee for allograft classification in 2014 and contributes to the working groups (22 transplant centres represented worldwide), and Banff recommendations delivered to the international transplant community. Pr. Loupy is expert for the FDA. Alexandre Loupy is a member of the American Society of Transplantation and gets the Clinical science investigator award from the AST in 2017. Dr. Alexandre Loupy was awarded the National Academy of Medicine Award for his work on "Renal transplantation, anti-HLA graft rejection, and biomarker identification". Dr Loupy is also involved in the French Society of Transplantation and in the European Society of Transplantation. Pr. Loupy was Associate Editor for the Transplantation Journal from 2014 to 2018, and still is at the American Journal of Transplantation. He is also referee for the New England Journal of Medicine, Nature Medicine, The Lancet, JAMA, the American Journal of Transplantation, Kidney International, Plos Medicine and the Journal of the American Society of Nephrology. Pr. Loupy has obtained in the past years several grants support for implementing cutting edge diagnostic tests at large scale. Pr Loupy is principal investigator and coordinator of international H2020 (EU-train) and national RHU (KTD-innov, iTRANSPLANT) projects.